
S15 Ep43: Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP Inhibition in Triple-Negative Breast Cancer
OncLive® On Air
00:00
Why target TROP2 and ADC design
Heather McArthur explains TROP2 biology, ADC chemistry, high DARs, and bystander effects relevant across breast cancer subtypes.
Play episode from 05:08
Transcript


